Magnetic resonance imaging metrics and their correlation with clinical outcomes in multiple sclerosis: a review of the literature and future perspectives
- 1 July 2008
- journal article
- review article
- Published by SAGE Publications in Multiple Sclerosis Journal
- Vol. 14 (6), 719-727
- https://doi.org/10.1177/1352458507088102
Abstract
Magnetic resonance imaging (MRI) has revolutionized the diagnosis and management of patients with multiple sclerosis (MS). Conventional MRI metrics are employed as primary endpoints in proof-of-concept clinical trials evaluating new drugs for MS and as secondary endpoints in definitive phase III trials. Metrics derived from non-conventional MRI techniques are now emerging and hold significant promise since they appear to be more correlated with the most disabling features of MS. However, none of these has been approved for use as a surrogate endpoint for accumulation of physical disability, which is the most important clinical endpoint of this disease. Taking into account the large numbers of patients needed, the extensive exposure to placebo, and the relatively long duration required for phase III clinical trials to show a meaningful effect on progression of disability, the need for a valid, reliable, and objective paraclinical marker of disease evolution cannot be overemphasized. This paper reviews the most up-to-date data regarding MRI techniques, their relationship with central nervous system pathology, as well as with clinical endpoints, and proposes future insights into the use of MRI metrics as surrogate endpoints in clinical trials of MS.Keywords
This publication has 100 references indexed in Scilit:
- A composite score to predict short-term disease activity in patients with relapsing-remitting MSNeurology, 2007
- Magnetization transfer histograms in clinically isolated syndromes suggestive of multiple sclerosisBrain, 2005
- Magnetic Resonance Spectroscopy in the Monitoring of Multiple SclerosisJournal of Neuroimaging, 2005
- Voxel‐based analysis of MTR images: A method to locate gray matter abnormalities in patients at the earliest stage of multiple sclerosisJournal of Magnetic Resonance Imaging, 2004
- Thalamic Involvement in Multiple Sclerosis: A Diffusion‐Weighted Magnetic Resonance Imaging StudyJournal of Neuroimaging, 2003
- Interferon beta-1b and intravenous methylprednisolone promote lesion recovery in multiple sclerosisMultiple Sclerosis Journal, 2001
- Relative contributions of brain and cervical cord pathology to multiple sclerosis disability: a study with magnetisation transfer ratio histogram analysisJournal of Neurology, Neurosurgery & Psychiatry, 2000
- Relationship between brain atrophy and disability: an 8-year follow-up study of multiple sclerosis patientsMultiple Sclerosis Journal, 2000
- Magnetic resonance diffusion tensor imaging for characterizing diffuse and focal white matter abnormalities in multiple sclerosisMagnetic Resonance in Medicine, 2000
- Axonal Transection in the Lesions of Multiple SclerosisNew England Journal of Medicine, 1998